Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers

類似資料

• Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival
  著者:: Prodeus, Aaron, 等
  出版事項: (2014)
• Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells
  著者:: Abdul-Wahid, Aws, 等
  出版事項: (2018)
• VISTA.COMP — an engineered checkpoint receptor agonist that potently suppresses T cell–mediated immune responses
  著者:: Prodeus, Aaron, 等
  出版事項: (2017)
• Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
  出版事項: (2020)
• Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
  著者:: Wang, Yiting, 等
  出版事項: (2020)